Trident Texofab Ltd.

BSE: 540726  SECTOR: Trading

28.9
-1.1 (-3.67%)

Price Summary

Today's High

₹ 30

Today's Low

₹ 28.9

52 Week High

₹ 49.5

52 Week Low

₹ 24

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.

Company Essentials

Market Cap

29.102589 Cr.

Enterprise Value

51.952121776 Cr.

No. of Shares

1.00701 Cr.

P/E

130.53

P/B

2.57

Face Value

₹ 10

Div. Yield

0%

Book Value (TTM)

₹  11.2534

CASH

0.081761606 Cr.

DEBT

22.931294382 Cr.

Promoter Holding

72.12%

EPS (TTM)

₹  0.2214

Sales Growth

4.67985867988374%

ROE

7.78781962681675 %

ROCE

12.470515697148 %

Profit Growth

0.891953443528162 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year4.68%
3 Year6.2%
5 Year7.77%

Profit Growth (in Cr.)

1 Year-32.6%
3 Year37.67%
5 Year36.66%

ROE%

1 Year7.79%
3 Year11.26%
5 Year8.91%

ROCE %

1 Year12.47%
3 Year13.89%
5 Year13.49%

Debt/Equity

1.956

Price to Cash Flow

-9.18

Interest Cover Ratio

1.55763884157374

CFO/PAT (5 Yr. Avg.)

0.656686682621245

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2019 72.12 0
Sep 2019 72.12 0
Jun 2019 71.94 0
Mar 2019 71.8 0
Dec 2018 71.6 0
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 60.8938649056148 days.
  • The company has a high promoter holding of 72.12%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 12.7809654615425.

 Limitations

  • The company has shown a poor revenue growth of 6.19853074980234% for the Past 3 years.
  • Company has negative cash flow from operations of -3.1717208.
  • The company has a low EBITDA margin of 2.39615616770645% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
Net Sales 22.38 19.92 22.39 1.27 15.63
Total Expenditure 21.2 18.47 20.94 1.08 14.85
Operating Profit 1.18 1.45 1.45 0.19 0.78
Other Income 0.08 0.07 0.09 0.03 0.19
Interest 0.81 1.02 0.75 0.57 0.6
Depreciation 0.21 0.21 0.21 0.2 0.2
Exceptional Items 0 -0.04 -0.01 0 0
Profit Before Tax 0.24 0.25 0.56 -0.55 0.18
Tax 0.11 0.02 0.21 -0.05 0.03
Profit After Tax 0.14 0.23 0.35 -0.5 0.14
Adjusted EPS (Rs) 0.01 0.02 0.04 -0.05 0.01

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 65.98 75.95 85.46 86.9 90.96
Total Expenditure 64.99 74.8 84.01 84.5 86.4
Operating Profit 0.99 1.15 1.45 2.4 4.56
Other Income 0.05 0.24 0.48 0.32 0.31
Interest 0.6 0.68 0.77 0.86 2.41
Depreciation 0.14 0.13 0.13 0.3 0.8
Exceptional Items -0.21 -0.02 0 0.14 -0.3
Profit Before Tax 0.09 0.56 1.04 1.69 1.35
Tax 0.03 0.23 0.29 0.42 0.49
Net Profit 0.06 0.33 0.75 1.27 0.86
Adjusted EPS (Rs.) 0.74 4.13 0.78 1.33 0.9

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 0.33 0.33 4 4.2 4.2
Total Reserves 3.13 3.46 4.27 6.8 7.66
Borrowings 0.51 5.18 4.17 9.25 11.5
Other N/C liabilities 0.01 0.02 0.02 0.01 0.22
Current liabilities 34 15.49 32.48 26.79 28.79
Total Liabilities 37.99 24.48 44.94 47.04 52.37
Assets
Net Block 1.33 1.25 1.56 2.36 9.27
Capital WIP 0 0 0 6.39 0.3
Investments 0.33 0.82 2.65 1.42 0.9
Loans & Advances 0.13 0.2 0.49 0.37 0.59
Other N/C Assets 0 0 0 0.42 1.37
Current Assets 36.2 22.21 40.23 36.08 39.94
Total Assets 37.99 24.48 44.94 47.04 52.37
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax 0.09 0.56 1.04 1.69 1.35
Adjustment 0.08 0.12 0.13 1.24 3.55
Working Capital Changes 0.61 -0.38 -3.19 -4.94 -7.56
Tax Paid -0.08 -0.17 -0.41 -0.74 -0.5
Operating Cash Flow 0.7 0.13 -2.45 -2.75 -3.17
Investing Cash Flow -0.1 -0.54 -2.27 -6.61 -2.41
Financing Cash Flow -0.63 2.11 3.09 9.59 5.27
Net Cash Flow -0.02 1.69 -1.62 0.22 -0.31

Corporate Actions

Ratings & Research Reports

Company Presentations

Company News

Trident Texofab Stock Price Analysis and Quick Research Report. Is Trident Texofab an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Trident Texofab has a PE ratio of 130.532971996387 which is high and comparatively overvalued .

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Trident Texofab has ROA of 1.72782818298564 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Trident Texofab has a Current ratio of 1.38713257171682 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Trident Texofab has a ROE of 7.78781962681675 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Trident Texofab has a D/E ratio of 1.956 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Trident Texofab has an Inventory turnover ratio of 13.7195068442912 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Trident Texofab has reported revenue growth of 4.67985867988374 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Trident Texofab for the current financial year is 4.73493299819763 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Trident Texofab is Rs 0 and the yield is 0 %.

Brief about Trident Texofab

X